Skip to main content
Premium Trial:

Request an Annual Quote

Evotec, PsychoGenics Partner on CNS Drug Discovery Services

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –Evotec today said that it has teamed up with PsychoGenics to offer pharmaceutical and biotech companies CNS drug discovery services.

The firms will offer clients access to their complementary drug discovery platforms for identifying and developing new therapeutics for central nervous system disorders. Financial and other terms of the agreement were not disclosed.

Tarrytown, NY-based PsychoGenics employs a proprietary bioinformatics platform to rapidly screen and optimize compounds for CAN activity.